Dornier MedTech Launches UroGPT™: The World’s First AI Tool Dedicated to Kidney Stone Patients

Dornier MedTech, a wholly owned subsidiary of innovative global leader in integrated urology Advanced MedTech Holdings (AMTH), today announced the launch of UroGPT™, a first-of-its-kind Artificial Intelligence (AI) tool designed to support kidney stone patients. This initiative marks a major milestone in the company’s commitment to leveraging digital innovation to empower kidney stone sufferers through patient-first healthcare solutions.

Advanced MedTech Acquires WIKKON, Strengthening Its Market Leading Position In Urology Medical Devices

Acquisition expands Advanced MedTech’s urological market access in China via a comprehensive nationwide sales & service network and an established local R&D, manufacturing & supply chain ecosystem

Integrated urology leader Advanced MedTech Holdings (AMTH or the Group) announced the acquisition of a majority interest in WIKKON, the Chinese market leader in urology and shock wave therapy devices. AMTH expects to acquire the remaining shares of WIKKON by the end of 2022. Based in the tech hub of Shenzhen, also known as China’s Silicon Valley, WIKKON specializes in the development and manufacturing of solutions to treat urological and orthopedic conditions such as kidney stones, erectile dysfunction and joint, muscle or tissue pain.

Dornier MedTech announces FDA clearance and CE mark approval for the revolutionary Nautilus urology table

The Dornier Nautilus brings the next level of flexibility, procedural versatility, and radiation management in urology tables.

The Nautilus offers new capabilities never before found in a urology table, combining a free-standing motorized urology table and the benefits of a mobile C-arm into one powerful, ergonomic platform. Capable of facilitating a wide range of urology procedures, Dornier’s flagship Nautilus will usher in a new era in table design in the urology treatment space.

Launch of 2022 Global Urology Survey on World Kidney Stone Day

World’s largest kidney stone patient experience survey finds 60% of respondents experienced first kidney stone before the age of 45.

Dornier MedTech is marking World Kidney Stone Day today with the launch of the 2022 Global Urology Survey report – the world’s largest survey of kidney stone patient experience. The findings were based on the collective responses of more than 1,000 patients from Dornier’s digital urology community, which garners 45 million patient and caregiver visits annually.

The world’s first MDR-certified integrated urology company

Achievement comes after two years of investment and effective team collaboration

Dornier MedTech (Dornier) became the world’s first integrated urology company to become certified under the European Union’s new medical device regulation (MDR). Clinicians are guaranteed the highest quality devices as they manage the growing prevalence of kidney stone disease in the region.